MedPath

贵州省科晖制药有限公司

Ownership
-
Established
1989-12-01
Employees
-
Market Cap
-
Website
www.gzkhzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

28

NMPA:28

Drug Approvals

千柏鼻炎胶囊

Approval Number
国药准字Z20194091
Approval Date
Aug 27, 2024
NMPA

银黄胶囊

Approval Number
国药准字Z20194076
Approval Date
Jul 11, 2024
NMPA

清凉防暑颗粒

Approval Number
国药准字Z20093243
Approval Date
Mar 29, 2024
NMPA

痛风舒片

Approval Number
国药准字Z20090524
Approval Date
Mar 29, 2024
NMPA

抗菌消炎胶囊

Approval Number
国药准字Z20080667
Approval Date
Oct 7, 2023
NMPA

炎可宁片

Approval Number
国药准字Z20083222
Approval Date
Jun 20, 2023
NMPA

哮喘片

Approval Number
国药准字Z20083047
Approval Date
Jan 3, 2023
NMPA

健胃消食片

Approval Number
国药准字Z20064051
Approval Date
Mar 21, 2021
NMPA

Paracetamol，Caffein，Atificial Cow-bezoar and Chlorphenamine maleate Tablets

Product Name
氨咖黄敏片
Approval Number
国药准字H52020624
Approval Date
Apr 13, 2020
NMPA

鸡血藤颗粒

Approval Number
国药准字Z20063239
Approval Date
Apr 13, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.